Home › Neuroendocrine Tumors › Pennsylvania › Pittsburgh
Neuroendocrine Tumors clinical trials in Pittsburgh, PA
3 studies for Neuroendocrine Tumors are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Pittsburgh
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- Philadelphia, PA11 studies
- Rochester, MN9 studies
- Columbus, OH8 studies
- St. Louis, MO8 studies
- Houston, TX8 studies
- Salt Lake City, UT8 studies
- Chicago, IL7 studies
- New York City, NY7 studies
- Cleveland, OH7 studies
- Cedar Rapids, IA7 studies
- Miami, FL7 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.